Save time and get answers to complex questions with AI chat
Lipitor vs generics what's the price gap?Does lipitor's effectiveness decrease with high fat meals?What is dabrafenib mesylate msn patent issue?Drug patent watch trametinib?Tenofovir generic patent?
See the DrugPatentWatch profile for aristada
Aristada (aripiprazole lauroxil) is a long-acting injectable antipsychotic for schizophrenia maintenance, given every 4 to 8 weeks. Aristada Initio is its one-time "initiator" version, used only as a single 675 mg dose on day 1 to rapidly establish therapeutic drug levels.[1]
Aristada Initio kickstarts treatment because standalone Aristada takes weeks to reach steady-state aripiprazole levels. Patients get Initio plus an oral aripiprazole dose on day 1, then start Aristada (441 mg, 882 mg, or 1320 mg) on day 8 or later—no oral meds needed after that.[1][2] Aristada alone requires 21 days of oral aripiprazole buildup first.
Initio converts faster to active aripiprazole via an extra metabolic step, bridging the gap until Aristada builds up. This reduces relapse risk during early treatment.[2]
Both carry similar risks—akathisia, weight gain, injection-site pain, sedation. Initio's single use limits cumulative exposure. Neither is for acute agitation.[1][3] Sources [1]: Aristada Initio Prescribing Information (Alkermes) [2]: FDA Approval Summary [3]: Drugs.com Comparison
Other Questions About Aristada :